Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  International Journal of Oncology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/IJO.24.1.97PMID 14654946
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FXYD Proteins: New Tissue‐ and Isoform‐Specific Regulators of Na,K‐ATPase

  2003cited by this paper
• Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer.

  2003cited by this paper
• Expanded Human Tissue Kallikrein Family – A Novel Panel of Cancer Biomarkers

  2002cited by this paper
• RNAi: nature abhors a double-strand.

  2002cited by this paper
• The polycomb group protein EZH2 is involved in progression of prostate cancer

  2002cited by this paper
• Proteome analysis of hepatocellular carcinoma.

  2002cited by this paper
• Establishment and characterization of androgen‐independent human prostate cancer LNCaP cell model

  2002cited by this paper
• Na(+)/K(+)-ATPase as a signal transducer.

  2002cited by this paper
• Antisense ferritin oligonucleotides inhibit growth and induce apoptosis in human breast carcinoma cells.

  2002cited by this paper
• p300 mediates androgen-independent transactivation of the androgen receptor by interleukin 6.

  2002cited by this paper
• Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer.

  2001cited by this paper
• Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.

  2001cited by this paper
• Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

  2001cited by this paper
• Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent.

  2001cited by this paper
• Identification of essential genes in cultured mammalian cells using small interfering RNAs.

  2001cited by this paper
• Involvement of Src and epidermal growth factor receptor in the signal-transducing function of Na+/K+-ATPase.

  2000cited by this paper
• Differentially Expressed Genes in Two LNCaP Prostate Cancer Cell Lines Reflecting Changes during Prostate Cancer Progression

  2000cited by this paper
• Regular review: tumour markers in malignancies.

  2000cited by this paper
• Cancer statistics, 2000

  2000cited by this paper
• PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer.

  2000cited by this paper
• Intracellular Reactive Oxygen Species Mediate the Linkage of Na+/K+-ATPase to Hypertrophy and Its Marker Genes in Cardiac Myocytes*

  1999cited by this paper
• Molecular Analysis of Two Mammary Carcinoma Cell Lines at the Transcriptional Level as a Model System for Progression of Breast Cancer

  1998cited by this paper
• Multiple Signal Transduction Pathways Link Na+/K+-ATPase to Growth-related Genes in Cardiac Myocytes

  1998cited by this paper
• Protein expression profiles in human breast ductal carcinoma and histologically normal tissue

  1997cited by this paper
• DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras.

  1997cited by this paper
• Elevated expression of ferritin H-chain mRNA in metastatic ovarian tumor.

  1996cited by this paper
• Site-directed mutagenesis of hamster complement C1S: characterization with an active form-specific antibody and possible involvement of C1S in tumorigenicity.

  1996cited by this paper
• Mat-8, a Novel Phospholemman-like Protein Expressed in Human Breast Tumors, Induces a Chloride Conductance in Xenopus Oocytes (*)

  1995cited by this paper
• neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors.

  1994cited by this paper
• Tumorigenicity of BALB3T3 A31 cells transfected with hamster‐complement‐C1s cDNA

  1994cited by this paper

• The insider's perspective: The intracellular complosome and immune cell dynamics in cancer.

  2026cites this paper
• FXYD3 Is Frequently Expressed in Pancreatic Ductal Adenocarcinoma but Does Not Predict Survival

  2025cites this paper
• Comprehensive analysis of alternative splicing across multiple transcriptomic cohorts reveals prognostic signatures in prostate cancer

  2023cites this paper
• FXYD3 enhances IL-17A signaling to promote psoriasis by competitively binding TRAF3 in keratinocytes

  2023cites this paper
• The Role οf Ion Channels in the Development and Progression of Prostate Cancer

  2023cites this paper
• Displacement of Native FXYD Protein From Na+/K+-ATPase With Novel FXYD Peptide Derivatives: Effects on Doxorubicin Cytotoxicity

  2022cites this paper
• PARK7/DJ-1 inhibition decreases invasion and proliferation of uveal melanoma cells

  2021cites this paper
• Na/K-ATPase: Their role in cell adhesion and migration in cancer.

  2021cites this paper
• FXYD proteins and sodium pump regulatory mechanisms

  2021cites this paper
• Clinical significance of P-class pumps in cancer

  2021cites this paper
• Complement System: Promoter or Suppressor of Cancer Progression?

  2020cites this paper
• V-ATPases and osteoclasts: ambiguous future of V-ATPases inhibitors in osteoporosis

  2018cites this paper
• Prognostic significance of sodium-potassium ATPase regulator, FXYD3, in human hepatocellular carcinoma

  2017cites this paper
• Silencing overexpression of FXYD3 protein in breast cancer cells amplifies effects of doxorubicin and γ-radiation on Na+/K+-ATPase and cell survival

  2016cites this paper
• FXYD-3 expression in relation to local recurrence of rectal cancer

  2016influential citation
• The antioxidant protein PARK7 plays an important role in cell resistance to Cisplatin-induced apoptosis in case of clear cell renal cell carcinoma.

  2016cites this paper
• Nitroxyl (HNO): A Possible Strategy for Fighting Cancer.

  2016cites this paper
• FXYD3 and TNFα mRNA Expression in Laryngeal Squamous Cell Carcinoma and their Correlation with Clinicopathologic Parameters

  2016cites this paper
• HNO suppresses LPS-induced inflammation in BV-2 microglial cells via inhibition of NF-κB and p38 MAPK pathways.

  2016cites this paper
• Retracted: Nitroxyl (HNO): A Reduced Form of Nitric Oxide with Distinct Chemical, Pharmacological, and Therapeutic Properties

  2016cites this paper
• Cancer: A Problem of Developmental Biology; Scientific Evidence for Reprogramming and Differentiation Therapy.

  2016cites this paper
• DJ-1: a promising marker in metastatic uveal melanoma

  2015cites this paper
• Role of DJ-1 siRNA in reverse sensitivity of breast cancer cells to chemotherapy and its possible mechanism.

  2015cites this paper
• Nitroxyl (HNO): A Reduced Form of Nitric Oxide with Distinct Chemical, Pharmacological, and Therapeutic Properties

  2015cites this paper
• MicroRNA-143 is a putative predictive factor for the response to fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer

  2015cites this paper
• Estrogen and tamoxifen up-regulate FXYD3 on breast cancer cells: assessing the differential roles of ER α and ZEB1

  2015cites this paper
• Antiandrogens Act as Selective Androgen Receptor Modulators at the Proteome Level in Prostate Cancer Cells

  2015cites this paper
• proteome level in prostate cancer cells

  2015cites this paper
• Activation of endogenous antioxidants as a common therapeutic strategy against cancer, neurodegeneration and cardiovascular diseases: A lesson learnt from DJ-1.

  2015cites this paper
• Na+/K+ ATPase inhibitors in cancer.

  2014cites this paper
• FXYD6: a novel therapeutic target toward hepatocellular carcinoma

  2014cites this paper
• Expression and clinical significance of FXYD3 in endometrial cancer

  2014cites this paper
• A systemic approach to cancer treatment: tumor cell reprogramming focused on endocrine-related cancers.

  2014cites this paper
• Up-Regulating the DJ-1 Gene to Stop the Progression of Parkinson's Disease

  2013cites this paper
• From Na+/K+-ATPase and cardiac glycosides to cytotoxicity and cancer treatment.

  2013cites this paper
• Overexpression of FXYD-3 Is Involved in the Tumorigenesis and Development of Esophageal Squamous Cell Carcinoma

  2013cites this paper
• Expression of DJ-1 in Endometrial Cancer: Close Correlation With Clinicopathological Features and Apoptosis

  2013cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology Editor

  2012cites this paper
• A preliminary sketch of horn cancer transcriptome in Indian zebu cattle.

  2012cites this paper
• PHENOTYPIC IMPACT OF ETV4 OVEREXPRESSION IN PROSTATE CARCINOGENESIS

  2012cites this paper
• The caspase 6 derived N-terminal fragment of DJ-1 promotes apoptosis via increased ROS production

  2012cites this paper
• FXYD3 (FXYD domain containing ion transport regulator 3)

  2012cites this paper
• Promising Urinary Protein Biomarkers for the Early Detection of Hepatocellular Carcinoma among High-Risk Hepatitis C Virus Egyptian Patients

  2012cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology FXYD 3 ( FXYD domain containing ion transport regulator 3 )

  2012cites this paper
• Upregulated DJ-1 promotes renal tubular EMT by suppressing cytoplasmic PTEN expression and Akt activation

  2011cites this paper
• Down-regulation of FXYD3 is induced by transforming growth factor-β signaling via ZEB1/δEF1 in human mammary epithelial cells.

  2011cites this paper
• FXYD Proteins Reverse Inhibition of the Na+-K+ Pump Mediated by Glutathionylation of Its β1 Subunit*

  2011cites this paper
• A Monoclonal Antibody Against Human FXYD6

  2011cites this paper
• FXYD3: A Promising Biomarker for Urothelial Carcinoma

  2011cites this paper
• Upregulated DJ-1 promotes renal tubular EMT by suppressing cytoplasmic PTEN expression and Akt activation

  2011cites this paper
• Expression and Significance of FXYD3 Protein in Gastric Adenocarcinoma

  2010cites this paper
• Module Network Inference from a Cancer Gene Expression Data Set Identifies MicroRNA Regulated Modules

  2010cites this paper
• Expression and Significance of FXYD-3 Protein in Gastric Adenocarcinoma

  2010cites this paper
• DJ‐1, an oncogene and causative gene for familial Parkinson's disease, is essential for SV40 transformation in mouse fibroblasts through up‐regulation of c‐Myc

  2010cites this paper
• Proteomic mining in the dysplastic liver of WHV/c‐myc mice – insights and indicators for early hepatocarcinogenesis

  2010cites this paper
• FXYD3 protein involved in tumor cell proliferation is overproduced in human breast cancer tissues.

  2009cites this paper
• Neurotrophin 3/TrkC‐regulated proteins in the human medulloblastoma cell line DAOY

  2009cites this paper
• A link between FXYD3 (Mat-8)-mediated Na,K-ATPase regulation and differentiation of Caco-2 intestinal epithelial cells.

  2009influential citation
• Expression of FXYD3 Protein in Relation to Biological and Clinicopathological Variables in Colorectal Cancers

  2009cites this paper
• RNA Interference for Cancer Therapy

  2009cites this paper
• FXYD3 expression in gliomas and its clinicopathological significance.

  2009cites this paper
• Expression of FXYD-3 is an independent prognostic factor in rectal cancer patients with preoperative radiotherapy.

  2009cites this paper
• Quantitative Proteomic Profiling of Prostate Cancer Reveals a Role for miR-128 in Prostate Cancer*

  2009cites this paper
• Proteomic analysis of apoptosis induced by xanthoangelol, a major constituent of Angelica keiskei, in neuroblastoma.

  2008cites this paper
• Expression and role of DJ-1 in leukemia.

  2008cites this paper
• Regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by DJ-1 in thyroid cancer cells.

  2008cites this paper
• Leupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cells.

  2008cites this paper
• DJ-1 Decreases Bax Expression through Repressing p53 Transcriptional Activity*

  2008cites this paper
• DJ‐1, a causative gene product of a familial form of Parkinson's disease, is secreted through microdomains

  2008cites this paper
• Secretion of DJ-1 into the serum of patients with Parkinson's disease.

  2008cites this paper
• Changes in gene expression induced by polycyclic aromatic hydrocarbons in the human cell lines HepG2 and A549.

  2008cites this paper
• FXYD3 knockdown by small interfering RNA inhibits cell proliferation and migration of oral squamous cell carcinoma cells

  2008cites this paper
• Progestins regulate genes that can elicit both proliferative and antiproliferative effects in breast cancer cells.

  2008cites this paper
• Interaction of Mat-8 (FXYD-3) with Na+/K+-ATPase in colorectal cancer cells.

  2007cites this paper
• Analysis of the HLA class I associated peptide repertoire in a hepatocellular carcinoma cell line reveals tumor‐specific peptides as putative targets for immunotherapy

  2007cites this paper
• FXYD proteins: new regulators of Na-K-ATPase.

  2006cites this paper
• Les protéines FXYD : nouveaux régulateurs de la Na,K-ATPase

  2006cites this paper
• Transcriptomic analysis of an in vitro murine model of ovarian carcinoma: Functional similarity to the human disease and identification of prospective tumoral markers and targets

  2006cites this paper
• Investigation of the presence and expression of the cyclophilin a pseudogene in NCI-H596 lung cell line and its expression in other cell lines

  2006cites this paper
• Establishment of specific antibodies that recognize C106-oxidized DJ-1.

  2006cites this paper
• Proteomics analysis of a novel compound: Cyclic RGD in breast carcinoma cell line MCF‐7

  2006cites this paper
• [FXYD proteins: novel regulators of Na,K-ATPase].

  2006cites this paper
• Structural and Functional Properties of Two Human FXYD3 (Mat-8) Isoforms*

  2006cites this paper
• FXYD3 is overexpressed in pancreatic ductal adenocarcinoma and influences pancreatic cancer cell growth

  2006cites this paper
• DJ-1 interacts with HIPK1 and affects H2O2-induced cell death

  2006cites this paper
• Pharmacological targeting of catalyzed protein folding: the example of peptide bond cis/trans isomerases.

  2006cites this paper
• Proteomic identification of differentially‐expressed genes in human gastric carcinomas

  2005cites this paper
• Expression profiles of genes in DJ-1-knockdown and L 166 P DJ-1 mutant cells.

  2005cites this paper
• Chemical Identification and Characterization of DJ-1 Protein in Human Fetal Amygdala

  2005cites this paper
• Association of DJ-1 with chaperones and enhanced association and colocalization with mitochondrial Hsp70 by oxidative stress

  2005cites this paper
• Stimulation of transforming activity of DJ-1 by Abstrakt, a DJ-1-binding protein.

  2005cites this paper
• Function of FXYD Proteins, Regulators of Na, K-ATPase

  2005cites this paper
• PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke.

  2005cites this paper
• DJ‐1 is present in a large molecular complex in human brain tissue and interacts with α‐synuclein

  2005cites this paper
• FXYD3 (Mat-8), a new regulator of Na,K-ATPase.

  2005cites this paper
• Identification of novel Myc target genes with a potential role in lymphomagenesis.

  2004cites this paper
• Differential control of apoptosis by DJ‐1 in prostate benign and cancer cells

  2004cites this paper